Postoperative surveillance recommendations for early stage colon cancer based on results from the clinical outcomes of surgical therapy trial

Vassiliki L. Tsikitis, Kishore Malireddy, Erin A. Green, Brent Christensen, Richard Whelan, Jace Hyder, Peter Marcello, Sergio Larach, David Lauter, Daniel J. Sargent, Heidi Nelson

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

Purpose: Intensive postoperative surveillance is associated with improved survival and recommended for patients with late stage (stage IIB and III) colon cancer. We hypothesized that stage I and IIA colon cancer patients would experience similar benefits. Patients and Methods: Secondary analysis of data from the Clinical Outcomes of Surgical Therapy trial was performed by analyzing results according to TNM stage; early (stage I and IIA, 537 patients) and late (stage IIB and III, 254 patients) stage disease. Five-year recurrence rates were higher in patients with late (35.7%) versus early stage disease (9.5%). Early and late stage salvage rates, recurrence patterns and methods of first detection were compared by χ2 test. Results: Salvage rates for early- and late-stage disease patients with recurrence were the same (35.9% v 37%; P = .9, respectively). Median survival after second surgery after recurrence was 51.2 and 35.8 months for early- and late-stage patients, respectively. Single sites of first recurrence did not significantly differ between early and late stage, but multiple sites of recurrence occurred less often in early-stage patients (3.6% v 28.6%, for early v late, respectively; P < .001). Methods of first detection of recurrence were not significantly different: carcinoembryonic antigen (29.1% v 37.4%), computed tomography scan (23.6% v 26.4%), chest x-ray (7.3% v 12.1%), and colonoscopy (12.7% v 8.8%), for early versus late stage disease, respectively. Conclusion: Patients with early-stage colon cancer have similar sites of recurrence, and receive similar benefit from postrecurrence therapy as late-stage patients; implementation of surveillance guidelines for early-stage patients is appropriate.

Original languageEnglish (US)
Pages (from-to)3671-3676
Number of pages6
JournalJournal of Clinical Oncology
Volume27
Issue number22
DOIs
StatePublished - Aug 1 2009

Fingerprint

Colonic Neoplasms
Recurrence
Therapeutics
Survival
Carcinoembryonic Antigen
Colonoscopy
Thorax
Tomography
X-Rays
Guidelines

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Medicine(all)

Cite this

Postoperative surveillance recommendations for early stage colon cancer based on results from the clinical outcomes of surgical therapy trial. / Tsikitis, Vassiliki L.; Malireddy, Kishore; Green, Erin A.; Christensen, Brent; Whelan, Richard; Hyder, Jace; Marcello, Peter; Larach, Sergio; Lauter, David; Sargent, Daniel J.; Nelson, Heidi.

In: Journal of Clinical Oncology, Vol. 27, No. 22, 01.08.2009, p. 3671-3676.

Research output: Contribution to journalArticle

Tsikitis, VL, Malireddy, K, Green, EA, Christensen, B, Whelan, R, Hyder, J, Marcello, P, Larach, S, Lauter, D, Sargent, DJ & Nelson, H 2009, 'Postoperative surveillance recommendations for early stage colon cancer based on results from the clinical outcomes of surgical therapy trial', Journal of Clinical Oncology, vol. 27, no. 22, pp. 3671-3676. https://doi.org/10.1200/JCO.2008.20.7050
Tsikitis, Vassiliki L. ; Malireddy, Kishore ; Green, Erin A. ; Christensen, Brent ; Whelan, Richard ; Hyder, Jace ; Marcello, Peter ; Larach, Sergio ; Lauter, David ; Sargent, Daniel J. ; Nelson, Heidi. / Postoperative surveillance recommendations for early stage colon cancer based on results from the clinical outcomes of surgical therapy trial. In: Journal of Clinical Oncology. 2009 ; Vol. 27, No. 22. pp. 3671-3676.
@article{8b272e2b32e04ab091b7f6f9375df6ed,
title = "Postoperative surveillance recommendations for early stage colon cancer based on results from the clinical outcomes of surgical therapy trial",
abstract = "Purpose: Intensive postoperative surveillance is associated with improved survival and recommended for patients with late stage (stage IIB and III) colon cancer. We hypothesized that stage I and IIA colon cancer patients would experience similar benefits. Patients and Methods: Secondary analysis of data from the Clinical Outcomes of Surgical Therapy trial was performed by analyzing results according to TNM stage; early (stage I and IIA, 537 patients) and late (stage IIB and III, 254 patients) stage disease. Five-year recurrence rates were higher in patients with late (35.7{\%}) versus early stage disease (9.5{\%}). Early and late stage salvage rates, recurrence patterns and methods of first detection were compared by χ2 test. Results: Salvage rates for early- and late-stage disease patients with recurrence were the same (35.9{\%} v 37{\%}; P = .9, respectively). Median survival after second surgery after recurrence was 51.2 and 35.8 months for early- and late-stage patients, respectively. Single sites of first recurrence did not significantly differ between early and late stage, but multiple sites of recurrence occurred less often in early-stage patients (3.6{\%} v 28.6{\%}, for early v late, respectively; P < .001). Methods of first detection of recurrence were not significantly different: carcinoembryonic antigen (29.1{\%} v 37.4{\%}), computed tomography scan (23.6{\%} v 26.4{\%}), chest x-ray (7.3{\%} v 12.1{\%}), and colonoscopy (12.7{\%} v 8.8{\%}), for early versus late stage disease, respectively. Conclusion: Patients with early-stage colon cancer have similar sites of recurrence, and receive similar benefit from postrecurrence therapy as late-stage patients; implementation of surveillance guidelines for early-stage patients is appropriate.",
author = "Tsikitis, {Vassiliki L.} and Kishore Malireddy and Green, {Erin A.} and Brent Christensen and Richard Whelan and Jace Hyder and Peter Marcello and Sergio Larach and David Lauter and Sargent, {Daniel J.} and Heidi Nelson",
year = "2009",
month = "8",
day = "1",
doi = "10.1200/JCO.2008.20.7050",
language = "English (US)",
volume = "27",
pages = "3671--3676",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "22",

}

TY - JOUR

T1 - Postoperative surveillance recommendations for early stage colon cancer based on results from the clinical outcomes of surgical therapy trial

AU - Tsikitis, Vassiliki L.

AU - Malireddy, Kishore

AU - Green, Erin A.

AU - Christensen, Brent

AU - Whelan, Richard

AU - Hyder, Jace

AU - Marcello, Peter

AU - Larach, Sergio

AU - Lauter, David

AU - Sargent, Daniel J.

AU - Nelson, Heidi

PY - 2009/8/1

Y1 - 2009/8/1

N2 - Purpose: Intensive postoperative surveillance is associated with improved survival and recommended for patients with late stage (stage IIB and III) colon cancer. We hypothesized that stage I and IIA colon cancer patients would experience similar benefits. Patients and Methods: Secondary analysis of data from the Clinical Outcomes of Surgical Therapy trial was performed by analyzing results according to TNM stage; early (stage I and IIA, 537 patients) and late (stage IIB and III, 254 patients) stage disease. Five-year recurrence rates were higher in patients with late (35.7%) versus early stage disease (9.5%). Early and late stage salvage rates, recurrence patterns and methods of first detection were compared by χ2 test. Results: Salvage rates for early- and late-stage disease patients with recurrence were the same (35.9% v 37%; P = .9, respectively). Median survival after second surgery after recurrence was 51.2 and 35.8 months for early- and late-stage patients, respectively. Single sites of first recurrence did not significantly differ between early and late stage, but multiple sites of recurrence occurred less often in early-stage patients (3.6% v 28.6%, for early v late, respectively; P < .001). Methods of first detection of recurrence were not significantly different: carcinoembryonic antigen (29.1% v 37.4%), computed tomography scan (23.6% v 26.4%), chest x-ray (7.3% v 12.1%), and colonoscopy (12.7% v 8.8%), for early versus late stage disease, respectively. Conclusion: Patients with early-stage colon cancer have similar sites of recurrence, and receive similar benefit from postrecurrence therapy as late-stage patients; implementation of surveillance guidelines for early-stage patients is appropriate.

AB - Purpose: Intensive postoperative surveillance is associated with improved survival and recommended for patients with late stage (stage IIB and III) colon cancer. We hypothesized that stage I and IIA colon cancer patients would experience similar benefits. Patients and Methods: Secondary analysis of data from the Clinical Outcomes of Surgical Therapy trial was performed by analyzing results according to TNM stage; early (stage I and IIA, 537 patients) and late (stage IIB and III, 254 patients) stage disease. Five-year recurrence rates were higher in patients with late (35.7%) versus early stage disease (9.5%). Early and late stage salvage rates, recurrence patterns and methods of first detection were compared by χ2 test. Results: Salvage rates for early- and late-stage disease patients with recurrence were the same (35.9% v 37%; P = .9, respectively). Median survival after second surgery after recurrence was 51.2 and 35.8 months for early- and late-stage patients, respectively. Single sites of first recurrence did not significantly differ between early and late stage, but multiple sites of recurrence occurred less often in early-stage patients (3.6% v 28.6%, for early v late, respectively; P < .001). Methods of first detection of recurrence were not significantly different: carcinoembryonic antigen (29.1% v 37.4%), computed tomography scan (23.6% v 26.4%), chest x-ray (7.3% v 12.1%), and colonoscopy (12.7% v 8.8%), for early versus late stage disease, respectively. Conclusion: Patients with early-stage colon cancer have similar sites of recurrence, and receive similar benefit from postrecurrence therapy as late-stage patients; implementation of surveillance guidelines for early-stage patients is appropriate.

UR - http://www.scopus.com/inward/record.url?scp=68949112336&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68949112336&partnerID=8YFLogxK

U2 - 10.1200/JCO.2008.20.7050

DO - 10.1200/JCO.2008.20.7050

M3 - Article

C2 - 19564531

AN - SCOPUS:68949112336

VL - 27

SP - 3671

EP - 3676

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 22

ER -